Pricing Log in Create free account

Palatin Technologies, Inc. (PTN) vs Tvardi Therapeutics, Inc. (TVRD)

Palatin Technologies, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Tvardi Therapeutics, Inc. is the larger, with a market value of $11.5M against $10.2M — 1.1× the size. Tvardi Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −55.3%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Palatin Technologies, Inc. leads on 8 and Tvardi Therapeutics, Inc. on 8.

Valuation

Metric PTN TVRD Biotechnology median
P/E 12.21 n/m 10.26
P/S 1.23 1.05 9.18
P/B 2.43 0.95 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 0.67 6.83 8.98
Earnings yield 8.19% (328.24%) (34.89%)
Free cash flow yield (83.75%) (353.24%) (24.52%)

Profitability

Metric PTN TVRD Biotechnology median
Gross margin 100.00% 146.85% 65.16%
Operating margin (65.74%) 0.00% 0.00%
Net margin (63.54%) 0.00% 0.00%
Free cash flow margin (103.07%) 0.00% 0.00%
Return on equity (877.60%) (126.19%) (50.12%)
Return on assets (142.11%) (85.08%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PTN TVRD Biotechnology median
Revenue growth (TTM) 110.89% (55.30%) 6.26%
EPS growth (last fiscal year) 90.80% 71.45% 29.88%
Revenue growth, 5-year CAGR 156.83% (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTN TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.61 1.87 4.89
Net debt to EBITDA 0.87 1.15 1.01

Dividend

Metric PTN TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PTN TVRD Biotechnology median
Market cap 10.17m 11.53m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack